Altogether, these data suggest that dysregulated AQP7 expression is linked to dysregulated insulin secretion, thereof suggesting AQP7 as a potential therapeutic target for human obesity-associated type 2 diabetes. Here, AQP7 is linked to obesity due to melanocortin 4 receptor deficiency.